Eads & Heald Wealth Management Sells 1,124 Shares of UnitedHealth Group Incorporated $UNH

Eads & Heald Wealth Management cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,646 shares of the healthcare conglomerate’s stock after selling 1,124 shares during the period. Eads & Heald Wealth Management’s holdings in UnitedHealth Group were worth $1,137,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of UNH. Brighton Jones LLC boosted its holdings in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its holdings in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. Patriot Financial Group Insurance Agency LLC lifted its holdings in UnitedHealth Group by 6.0% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 3,729 shares of the healthcare conglomerate’s stock valued at $1,953,000 after purchasing an additional 211 shares in the last quarter. RDA Financial Network increased its stake in shares of UnitedHealth Group by 3.4% in the first quarter. RDA Financial Network now owns 9,282 shares of the healthcare conglomerate’s stock worth $4,861,000 after purchasing an additional 304 shares in the last quarter. Finally, ARS Wealth Advisors Group LLC lifted its stake in shares of UnitedHealth Group by 3.6% during the 1st quarter. ARS Wealth Advisors Group LLC now owns 28,650 shares of the healthcare conglomerate’s stock valued at $15,005,000 after buying an additional 1,004 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.8%

Shares of UNH opened at $360.17 on Monday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company’s fifty day simple moving average is $307.84 and its 200-day simple moving average is $353.45. The company has a market cap of $326.20 billion, a P/E ratio of 15.61, a P/E/G ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period last year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on UNH. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a report on Saturday, September 27th. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Truist Financial raised their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Finally, Bank of America increased their target price on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a research report on Monday, August 18th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.